Visual Abstract
Chronic kidney disease (CKD) is a long-term complication of diabetes affecting millions of people worldwide. CKD screening is recommended annually for patients with type 1 diabetes (T1D) with duration of ≥5 years. Diabetes drugs like SGLT-2 inhibitors, approved for T1D patients in Europe but not in the US, have been found to improve renal outcomes. In this study, from September-November 2020, adults with T1D in the US (n=1,561), Canada (n=350), Italy (n=301), Sweden (n=120), Germany (n=380), France (n=298), UK (n=370), and Netherlands (n=180) from an opted-in research panel rated their level of agreement with statements about CKD risk and renoprotective therapies. Health and demographic information were also collected. More respondents in the US, Italy, and Canada strongly agreed that diabetes increases CKD risk than those in Sweden, UK, and Netherlands (61%, 58%, 57% vs. 44%, 42%, 38%). Across most countries, PWD who had received a screening for CKD were more likely to strongly agree that having diabetes increases CKD risk. In the US, Canada, Sweden, and the UK, those who had been screened were more likely to indicate awareness of diabetes drugs’ renoprotective benefits; however, overall awareness was low, especially among European respondents. This data emphasizes the importance of regular screenings and improving awareness among patients to prevent CKD and further complications.
E. Ye: Other Relationship; Self; dQ&A. J. Stevenson: Other Relationship; Self; Abbott, Ascensia Diabetes Care, Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, LifeScan, Medtronic, Roche Diabetes Care, Senseonics, Tandem Diabetes Care. J. Tait: Other Relationship; Self; dQ&A Market Research Inc. R. Gowen: Other Relationship; Self; dQ&A. S. Suhl: Other Relationship; Self; dQ&A has several clients (>10) in the diabetes field. C. Florissi: Other Relationship; Self; Abbott Diabetes, Ascensia Diabetes Care, Dexcom, Inc., Insulet Corporation, LifeScan, Lilly Diabetes, Medtronic, Roche Diabetes Care, Senseonics, Tandem Diabetes Care. C. Pang: Employee; Self; dQ&A Market Research Inc. R. Wood: Research Support; Self; Abbott Diabetes, American Diabetes Association, Ascensia Diabetes Care, Boehringer Ingelheim International GmbH, Dexcom, Inc., Eli Lilly and Company, Insulet Corporation, Medtronic, Novo Nordisk Inc., Sanofi.
